Valuation: BELE LIFEUT

Market Cap 46.6M 40.73M 37.43M 34.89M 66.18M 4.44B 67.19M 449M 175M 2.18B 175M 171M 7.51B P/E 2022 *
-
P/E 2023 210x
Enterprise Value 46.65M 40.78M 37.48M 34.94M 66.26M 4.44B 67.27M 450M 175M 2.18B 175M 171M 7.52B EV / Sales 2022 *
-
EV / Sales 2023 -
Free-Float
-
Yield 2022 *
-
Yield 2023 -

Financials

2022 2023
Net sales - -
Net income -35.39K -30.94K -28.43K -26.5K -50.26K -3.37M -51.03K -341K -133K -1.66M -133K -130K -5.71M 404K 353K 324K 302K 574K 38.45M 582K 3.89M 1.51M 18.9M 1.52M 1.48M 65.12M
Net Debt 1.09M 955K 878K 818K 1.55M 104M 1.58M 10.54M 4.1M 51.13M 4.1M 4.01M 176M 56.58K 49.46K 45.46K 42.37K 80.37K 5.39M 81.58K 546K 212K 2.65M 212K 208K 9.13M
Logo BELE LIFEUT
OSR Holdings, Inc. is a global healthcare company, dedicated to advancing healthcare outcomes and improving the quality of life for people and their families. The Company is focused on building and developing a portfolio of transformative therapies and healthcare solutions. The Company's operating businesses (through its three wholly owned subsidiaries) include developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases and neurovascular intervention medical device and systems distribution in Korea. The Company has business operations in the United States, Europe and South Korea.
Employees
-
Sector
-